Literature DB >> 8712197

Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease.

D M Morens1, A Grandinetti, J W Davis, G W Ross, L R White, D Reed.   

Abstract

To investigate the association between idiopathic Parkinson disease (IPD) and reduced frequency of prior cigarette smoking, the authors compared the 29-year follow-up mortality rates and IPD incidence rates of men who were either cigarette smokers or nonsmokers at the time of enrollment in the Honolulu Heart Study (1965-1968). Based on IPD cases detected up to June 30, 1994, the age-adjusted incidence rate in smokers was less than half that in nonsmokers: 34.4 versus 94.2 cases per 100,000 person-years of pre-illness follow-up, respectively. When data were stratified by 5-year age group, lower IPD incidence in smokers was observed at all ages between 50 and 90 years. Age-specific mortality trends for smokers and nonsmokers with and without IPD suggested that increased mortality in IPD patients was mostly associated with IPD itself and not with smoking. The slight excess mortality in smokers without IPD, versus nonsmokers without IPD, appeared insufficient to account for the "missing" incident IPD cases in smokers. These IPD incidence and mortality data are not highly consistent with the "selective mortality" hypothesis, which attributes reduced prior smoking frequency, typically reported by persons with IPD, to accelerated mortality in undiagnosed IPD-affected persons who smoke. The "protective" association of cigarette smoking with IPD occurrence may thus be real, suggesting the need for further study of biologic mechanisms of protection.

Entities:  

Mesh:

Year:  1996        PMID: 8712197     DOI: 10.1093/oxfordjournals.aje.a008941

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

1.  Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Douglas G Kondo; Xian-Feng Shi; Kelly J Lundberg; Tracy L Hellem; Rebekah S Huber; Erin C McGlade; Eun-Kee Jeong; Perry F Renshaw
Journal:  Am J Drug Alcohol Abuse       Date:  2015-04-14       Impact factor: 3.829

2.  Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

3.  Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks.

Authors:  M Alkondon; E F Pereira; H M Eisenberg; E X Albuquerque
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  Interaction of methamphetamine abuse, tobacco abuse, and gender in the brain.

Authors:  Joseph O'Neill
Journal:  Am J Drug Alcohol Abuse       Date:  2015-06-29       Impact factor: 3.829

5.  Temporal relationship between cigarette smoking and risk of Parkinson disease.

Authors:  E L Thacker; E J O'Reilly; M G Weisskopf; H Chen; M A Schwarzschild; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

6.  Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease.

Authors:  Paola Costa-Mallen; Cyrus P Zabetian; Shu-Ching Hu; Pinky Agarwal; Dora Yearout; Harvey Checkoway
Journal:  J Neural Transm (Vienna)       Date:  2016-06-27       Impact factor: 3.575

7.  Factors associated with kyphosis progression in older women: 15 years' experience in the study of osteoporotic fractures.

Authors:  Deborah M Kado; Mei-Hua Huang; Arun S Karlamangla; Peggy Cawthon; Wendy Katzman; Teresa A Hillier; Kristine Ensrud; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

8.  Epidemiology of Parkinson's disease.

Authors:  Meike Kasten; Annabel Chade; Caroline M Tanner
Journal:  Handb Clin Neurol       Date:  2007

Review 9.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

10.  Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.

Authors:  Manuel B Huber; Maximilian Präger; Kathryn Coyle; Doug Coyle; Adam Lester-George; Marta Trapero-Bertran; Bertalan Nemeth; Kei Long Cheung; Renee Stark; Matthias Vogl; Subhash Pokhrel; Reiner Leidl
Journal:  Addiction       Date:  2017-12-15       Impact factor: 6.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.